In 1984, the New England Journal of Medicine ( NEJM ) began requiring authors of research papers to disclose financial relationships with the pharmaceutical or device industry. The policy was controversial then, and even a decade later still faced criticism
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/07/16/to-support-physician-decision-making-re-evaluate-industry-funding-of-science/
Posted
Jul 16 2015, 06:25 AM
by
Health Affairs Blog
Filed under: Physicians, Quality, Research, Featured, Costs and Spending, Drugs and Medical Technology, Health Professionals, NIH, FDA, Industry, Science, NEJM, Cochrane, scientific funding, BMJ, Christopher Robertson